CA - Bausch Health reaffirms 2025 revenue target of $4.95B-$5.1B as debt reduction and pipeline expansion advance
2025-07-30 23:31:32 ET
More on Bausch Health Companies
- Bausch Health Companies Inc. (BHC) Q2 2025 Earnings Call Transcript
- Bausch Health: Repricing Potential Driven By Deleveraging
- Bausch Health Companies Q2 2025 Earnings Preview
- Bausch Health to acquire liver drug developer Durect for $1.75 per share
- Seeking Alpha’s Quant Rating on Bausch Health Companies